Applied Immune Technologies

Applied Immune Technologies Ltd. is engaged in the development of therapeutic molecules aimed at treating cancer, viral, and autoimmune diseases. The company specializes in T-Cell Receptor-Like (TCRL) antibodies that target intracellular-derived peptides for both therapeutic and diagnostic purposes. These antibodies have applications in pathology, vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in various diseases. Established in 2006 and based in Haifa, Israel, Applied Immune Technologies was previously known as BioMimic Pharma. The company operates as a subsidiary of Adicet Bio, Inc.